Turing Pharmaceuticals - M&A Summary and Business Overview

Life ScienceCompany

Turing Pharmaceuticals M&A Summary

Turing Pharmaceuticals has acquired 1 company. It has also divested 1 asset.

Turing Pharmaceuticals has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

Turing Pharmaceuticals Business Overview

Where is Turing Pharmaceuticals headquartered?

Turing Pharmaceuticals is headquartered in New York, New York.

What sector is Turing Pharmaceuticals in?

Turing Pharmaceuticals is a life science company.

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity1
    • M&A Sell Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 2

Turing Pharmaceuticals LLC

1177 Avenue of the Americas, 39th Floor,
New York, New York 10036
United States,
(646) 356-5577
www.turingpharma.com

Turing Pharmaceuticals LLC is a privately-held biopharmaceutical company with offices in New York City and Zug, Switzerland. Turing focuses on developing and commercializing innovative treatments for serious diseases and conditions across a broad range of therapeutic areas, for which there are currently limited or no treatment options. Products being developed include intranasal ketamine for a variety of mood disorders and Syntocinon® (oxytocin nasal solution) for multiple indications. Vecamyl® (mecamylamine HCl tablets) for hypertension is Turing’s first commercial product.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 1 - - - - - 1
Sell (0.0/yr) # 1 - - - - - 1
  2

Most Recent M&A

Company Date Value Type
Turing Pharmaceuticals - Intranasal Ketamine Program 2016-05-03 - Divestiture
New York, New York
Impax Laboratories - Daraprim 2015-08-10 - Divestiture
Hayward, California
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) - 1 (100%) -
Total 1 - 1 -

By Geo

State/Country Buy Value Sell Value
United States 1 - 1 -
  California 1 - - -
  New York - - 1 -
Total 1 - 1 -

M&A Connections

Deals
Acquired from
Strategic(s)
100%
1 (100%)
Divested to
Strategic(s)
100%
1 (100%)

 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.